Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
Sign Up to like & getrecommendations! Published in 2020 at "Archives of Gynecology and Obstetrics"
DOI: 10.1007/s00404-020-05477-7
Abstract: Purpose Presence of circulating tumor cells (CTCs) is associated with impaired clinical outcome in several solid cancers. Limited data are available on the significance of CTCs in gynaecological malignancies. The aims of the present study… read more here.
Keywords: peritoneal cancer; tube peritoneal; fallopian tube; ovarian fallopian ... See more keywords
Niraparib: A Review in Ovarian Cancer
Sign Up to like & getrecommendations! Published in 2018 at "Targeted Oncology"
DOI: 10.1007/s11523-018-0582-1
Abstract: Niraparib (Zejula®), a poly (ADP-ribose) polymerase (PARP) inhibitor, is approved for the maintenance treatment of recurrent, epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are in complete or partial response to platinum-based… read more here.
Keywords: peritoneal cancer; tube primary; fallopian tube; ovarian fallopian ... See more keywords
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study.
Sign Up to like & getrecommendations! Published in 2018 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2018.08.027
Abstract: PURPOSE Bevacizumab (BV) monotherapy leads to compensatory upregulation of multiple signaling pathways, resulting in mTOR activation. We evaluated combining BV and everolimus (EV), an mTOR kinase inhibitor, to circumvent BV-resistance in women with recurrent or… read more here.
Keywords: bevacizumab; fallopian tube; ovarian fallopian; persistent ovarian ... See more keywords
Skin metastases in epithelial ovarian and fallopian tube carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000007798
Abstract: Abstract This study aimed to investigate the clinical features and outcomes of skin metastasis in ovarian and fallopian tube carcinomas. We studied patients with epithelial ovarian or fallopian tube carcinoma who developed skin metastasis from… read more here.
Keywords: carcinoma; fallopian tube; ovarian fallopian; metastasis ... See more keywords
Clinical impact of pre‐treatment FDG‐PET/CT staging of primary ovarian, fallopian tube, and peritoneal cancers in women
Sign Up to like & getrecommendations! Published in 2019 at "Acta Obstetricia et Gynecologica Scandinavica"
DOI: 10.1111/aogs.13726
Abstract: To assess the clinical impact of preoperative fludeoxyglucose (FDG) with positron emission tomography (PET) and computed tomography (CT) in women with ovarian, fallopian tube, or peritoneal cancer with focus on consequences of added findings (AFs). read more here.
Keywords: tube peritoneal; fallopian tube; ovarian fallopian; fdg ... See more keywords
Cell type-specific genotoxicity in estrogen-exposed ovarian and fallopian epithelium
Sign Up to like & getrecommendations! Published in 2020 at "BMC Cancer"
DOI: 10.1186/s12885-020-07524-7
Abstract: Background Loss of the genomic stability jeopardize genome stability and promote malignancies. A fraction of ovarian cancer (OvCa) arises from pathological mutations of DNA repair genes that result in highly mutagenic genomes. However, it remains… read more here.
Keywords: epithelium; ovarian fallopian; estrogen; damage ... See more keywords
Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers
Sign Up to like & getrecommendations! Published in 2022 at "In Vivo"
DOI: 10.21873/invivo.12980
Abstract: Abstract Background/Aim: The 2014 International Federation of Gynecology and Obstetrics (FIGO) classification subdivides patients with stage IIIA1 ovarian, fallopian tube, and peritoneal cancers by the greatest dimension of metastatic lymph node without supporting evidence. This… read more here.
Keywords: tube peritoneal; stage; fallopian tube; stage iiia1 ... See more keywords
Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Nutrients"
DOI: 10.3390/nu14235183
Abstract: Background: Discontinuing chemotherapy worsens cancer prognosis. This study aimed to investigate the relationship between nutritional status at the start of chemotherapy and chemotherapy discontinuation in patients with ovarian, fallopian tube, and primary peritoneal cancer. Methods:… read more here.
Keywords: nutritional status; car; chemotherapy; cancer ... See more keywords
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gynecologic Oncology"
DOI: 10.3802/jgo.2022.33.e78
Abstract: Objective To assess the incidence of bevacizumab-associated gastrointestinal (GI) perforation during first-line treatment of patients with ovarian, fallopian tube, or peritoneal cancer receiving neoadjuvant chemotherapy (NAC) in Japanese real-world clinical practice. Methods A retrospective study… read more here.
Keywords: ovarian fallopian; perforation; first line; line treatment ... See more keywords